A closed-loop cholesterol shunt controlling experimental dyslipidemia

Area of Science:

• Biotechnology and Genetic Engineering
• Metabolic Disorders and Cardiovascular Health
• Synthetic Biology Applications

Background:

• Hypercholesterolemia, characterized by dysregulated lipid metabolism, is a primary risk factor for atherosclerosis and cardiovascular diseases.
• Current therapeutic strategies for dyslipidemia face challenges in real-time monitoring and sustained regulation.
• The need for innovative approaches to restore and maintain cholesterol homeostasis is critical.

Purpose of the Study:

• To develop a designer genetic circuit, the Cholesterol Homeostasis and Regulation Module (CHARM), for real-time sensing and regulation of cholesterol levels.
• To engineer a closed-loop system that strengthens the body's innate cholesterol homeostasis machinery.
• To evaluate the efficacy of CHARM in restoring cholesterol balance in a preclinical model.

Main Methods:

• Engineered a synthetic genetic circuit (CHARM) utilizing a fusion protein (KRAB-SREBP1a) as a cholesterol sensor.
• Integrated a synthetic expression module with SRE operator sites to control therapeutic protein production.
• Implanted microencapsulated CHARM-transgenic human cells into hypercholesterolemic mice.

Main Results:

• CHARM successfully sensed elevated cholesterol levels in real time.
• Implantation of CHARM-transgenic cells rapidly restored cholesterol homeostasis in hypercholesterolemic mice.
• Stable maintenance of cholesterol homeostasis was achieved through the closed-loop regulation of the genetic circuit.

Conclusions:

• The CHARM genetic circuit represents a promising synthetic biology approach for managing hypercholesterolemia.
• This engineered system demonstrates the potential for closed-loop, real-time regulation of metabolic disorders.
• CHARM offers a novel strategy for restoring and maintaining cholesterol balance, potentially reducing cardiovascular disease risk.